Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis

被引:2
|
作者
Pezzella, F
Pastorino, U
Tagliabue, E
Andreola, S
Sozzi, G
Gasparini, G
Menard, S
Gatter, KC
Harris, AL
Fox, S
Buyse, M
Pilotti, S
Pierotti, M
Rilke, F
机构
[1] ROYAL BROMPTON HOSP, DEPT THORAC SURG, LONDON SW3 6LY, ENGLAND
[2] UNIV OXFORD, DEPT CELLULAR SCI, OXFORD, ENGLAND
[3] UNIV OXFORD, IMPERIAL CANC RES FUND, CLIN ONCOL UNIT, OXFORD, ENGLAND
[4] IST NAZL TUMORI, DIV PATHOL EXPT ONCOL E & A, I-20133 MILAN, ITALY
[5] ST BORTOLO HOSP, DEPT ONCOL, VICENZA, ITALY
[6] INST DRUG DEV ID2, BRUSSELS, BELGIUM
来源
AMERICAN JOURNAL OF PATHOLOGY | 1997年 / 151卷 / 05期
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Neoplastic growth is usually dependent on blood supply, and it is commonly accepted that this is provided by the formation of new vessels. However, tumors may be able to grow without neovascularization if they find a suitable vascular bed available, We have investigated the pattern of vascularization in a series of 500 primary stage I non-small-cell lung carcinomas, Immunostaining of endothelial cells has highlighted four distinct patterns of vascularization. Three patterns (which we called basal, papillary, and diffuse) have in common the destruction of normal lung and the production of newly formed vessels and stroma, The fourth pattern, which we called alveolar or putative nonangiogenic, was observed in 16% (80/500) of the cases and is characterized by lack of parenchymal destruction and absence of both tumor-associated stroma and new vessels, The only vessels present were the ones in the alveolar septa, and their presence highlighted, through the whole tumor, the lung alveoli filled up by the neoplastic cells, This observation suggests that, if an appropriate vascular bed is available, a tumor can exploit it and grows without inducing neo-angiogenesis. This could have implications for strategies aimed at inhibiting tumor growth by vascular targeting or inhibition of angiogenesis.
引用
收藏
页码:1417 / 1423
页数:7
相关论文
共 50 条
  • [21] Cetuximab and biomarkers in non-small-cell lung carcinoma
    Patil, Nitin
    Abba, Mohammed
    Allgayer, Heike
    BIOLOGICS-TARGETS & THERAPY, 2012, 6 : 221 - 231
  • [22] Targeted therapy of non-small-cell lung carcinoma
    Tiwari, Divya
    Brodie, Seth A.
    Brandes, Johann C.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2012, 6 (01) : 41 - 56
  • [23] CHEMOTHERAPY OF METASTATIC NON-SMALL-CELL CARCINOMA OF THE LUNG
    RUCKDESCHEL, JC
    HEMATOLOGICAL ONCOLOGY, 1992, 10 (01) : 25 - 30
  • [24] Pneumopericardium as a non-small-cell lung carcinoma complication
    Kubisa, Anna
    Lesinska, Anna
    Dec, Pawel
    Szewczak-Glodek, Malgorzata
    Kochanowski, Leszek
    Kubisa, Bartosz
    Feledyk, Grzegorz
    Czarnecka, Michalina
    Wojcik, Janusz
    Grodzki, Tomasz
    KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA, 2016, 13 (03): : 257 - 259
  • [25] PORTable indications in non-small-cell lung carcinoma
    Machtay, Mitchell
    ONCOLOGY-NEW YORK, 2008, 22 (03): : 315 - +
  • [26] Itraconazole Inhibits Angiogenesis and Tumor Growth in Non-Small Cell Lung Cancer
    Aftab, Blake T.
    Dobromilskaya, Irina
    Liu, Jun O.
    Rudin, Charles M.
    CANCER RESEARCH, 2011, 71 (21) : 6764 - 6772
  • [27] p53 and angiogenesis in non-small-cell lung cancer
    Giatromanolaki, A
    Koukourakis, MI
    BRITISH JOURNAL OF CANCER, 1998, 77 (05) : 850 - 851
  • [28] Angiogenesis inhibitors in the treatment of non-small-cell lung cancer (NSCLC)
    Carcereny Costa, Enric
    Vinolas Segarra, Nuria
    Gascon Vilaplana, Pere
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2008, 10 (04): : 198 - 203
  • [29] p53 and angiogenesis in non-small-cell lung cancer
    A Giatromanolaki
    MI Koukourakis
    British Journal of Cancer, 1998, 77 : 850 - 851
  • [30] Angiogenesis inhibitors in the treatment of non-small-cell lung cancer (NSCLC)
    Enric Carcereny Costa
    Núria Viñolas Segarra
    Pere Gascón Vilaplana
    Clinical and Translational Oncology, 2008, 10